Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾
main product photo

Recombinant Human Serpin A1/alpha-1-Antitrypsin Protein, CAS No.9041-92-3

Features and benefits
  • Expression System: Oryza sativa
  • Accession #: P01009
  • Protein Tag: No tag
  • Bioactivity: ≥0.70mg active AAT/mg total protein
  • Endotoxin Concentration: <1.0 EU/mg
Item Number
rp142729
Grouped product items
SKUSizeAvailabilityPrice Qty
rp142729-10μg
10μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$49.90
rp142729-50μg
50μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$99.90
rp142729-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$139.90
rp142729-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$999.90
Add to Wish List Compare
Bulk Order  DATASHEET

GMP, ≥90% (SDS-PAGE), Active, Oryza sativa, No tag, 1-418 aa

View related series
Click to view protein information: SERPINA1
Accession#:P01009 alpha 1 Antitrypsin Gene ID:5265 Serpin A1 SERPINA1

Basic Description

Product NameRecombinant Human Serpin A1/alpha-1-Antitrypsin Protein, CAS No.9041-92-3
SynonymsAlpha-1 protease inhibitor | Alpha-1-antiproteinase | Serpin A1 | A1AT | AAT | MGC23330 | alpha 1-Antitrypsin | alpha 1-Proteinase Inhibitor | Alpha-1 protease inhibitor | Alpha-1-antiproteinase | alpha-1-antitrypsin | antitrypsin), member 1 | member 1 |
GradeActiBioPure™, Animal Free, Bioactive, Carrier Free, Low Endotoxin
Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Low Endotoxin, ≥90%(SDS-PAGE)
Biochemical and Physiological MechanismsInhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in
Bioactivity≥0.70mg active AAT/mg total protein
Endotoxin Concentration<1.0 EU/mg
Expression SystemOryza sativa
SpeciesHuman
Amino Acids1-418 aa
Protein TagNo tag
Accession #P01009
Predicted molecular weight46.7 kDa

Product Specifications

FormLyophilized
ReconstitutionReconstitute in sterile PBS to a concentration of 100-200 μg/ml. Further dilutions should be made in appropriate buffered solutions. After reconstitution, store at 4℃ short term (2-7 days), store at -20℃ long term.
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -20 ℃ for 36 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS9041-92-3

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

 SDS

 Specification Sheet

FAQs and Articles

FAQ
Aladdin® Target Proteins
Categories: Technical articles
Tags:
Cytokines Drug development Target Proteins Drug Targets Receptors Immune Checkpoints Cell Surface Markers Signaling Pathways

References

1. Niemann, M A MA, Narkates, A J AJ and Miller, E J EJ..  (1992)  Isolation and serine protease inhibitory activity of the 44-residue, C-terminal fragment of alpha 1-antitrypsin from human placenta..  Matrix (Stuttgart, Germany),      [PMID:1406456]
2. Wu, Y Y and Foreman, R C RC..  (1991)  The molecular genetics of alpha 1 antitrypsin deficiency..  BioEssays : news and reviews in molecular, cellular and developmental biology,      [PMID:1859394]
3. Seyama, K K and 5 more authors..  (1991)  Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone..  The Journal of biological chemistry,    (5):   [PMID:1905728]
4. Tanaka, N N and 5 more authors..  (1991)  Characterization of a 54 kDa, alpha 1-antitrypsin-like protein isolated from ascitic fluid of an endometrial cancer patient..  Japanese journal of cancer research : Gann,      [PMID:1906855]
5. Curiel, D T DT, Vogelmeier, C C, Hubbard, R C RC, Stier, L E LE and Crystal, R G RG..  (1990)  Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele..  Molecular and cellular biology,      [PMID:1967187]
6. Okayama, H H, Brantly, M M, Holmes, M M and Crystal, R G RG..  (1991)  Characterization of the molecular basis of the alpha 1-antitrypsin F allele..  American journal of human genetics,      [PMID:2035534]
7. Graham, A A, Kalsheker, N A NA, Bamforth, F J FJ, Newton, C R CR and Markham, A F AF..  (1990)  Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115----Ser) and (Pi) Z Wrexham (Ser-19----Leu)..  Human genetics,      [PMID:2227940]
8. Frazier, G C GC, Siewertsen, M A MA, Hofker, M H MH, Brubacher, M G MG and Cox, D W DW..  (1990)  A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure..  The Journal of clinical investigation,      [PMID:2254451]
9. Matsunaga, E E and 5 more authors..  (1990)  Molecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, Mnichinan..  American journal of human genetics,      [PMID:2309708]
10. Holmes, M D MD, Brantly, M L ML, Curiel, D T DT, Weidinger, S S and Crystal, R G RG..  (1990)  Characterization of the normal alpha 1-antitrypsin allele Vmunich: a variant associated with a unique protein isoelectric focusing pattern..  American journal of human genetics,      [PMID:2316526]
11. Faber, J P JP, Weidinger, S S and Olek, K K..  (1990)  Sequence data of the rare deficient alpha 1-antitrypsin variant PI Zaugsburg..  American journal of human genetics,      [PMID:2339709]
12. Holmes, M D MD, Brantly, M L ML, Fells, G A GA and Crystal, R G RG..  (1990)  Alpha 1-antitrypsin Wbethesda: molecular basis of an unusual alpha 1-antitrypsin deficiency variant..  Biochemical and biophysical research communications,    (16):   [PMID:2390072]
13. Graham, A A and 5 more authors..  (1990)  Characterisation of the alpha-1-antitrypsin M3 gene, a normal variant..  Human genetics,      [PMID:2394452]
14. Graham, A A and 5 more authors..  (1989)  Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys)..  Human genetics,      [PMID:2606478]
15. and Kalsheker, N N..  (1989)  Alpha 1-antitrypsin: structure, function and molecular biology of the gene..  Bioscience reports,      [PMID:2669992]
16. Hofker, M H MH and 7 more authors..  (1989)  A Pro----Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen..  Human genetics,      [PMID:2784123]
17. Engh, R R and 5 more authors..  (1989)  The S variant of human alpha 1-antitrypsin, structure and implications for function and metabolism..  Protein engineering,      [PMID:2785270]
18. Fraizer, G C GC, Harrold, T R TR, Hofker, M H MH and Cox, D W DW..  (1989)  In-frame single codon deletion in the Mmalton deficiency allele of alpha 1-antitrypsin..  American journal of human genetics,      [PMID:2786335]
19. Nukiwa, T T, Brantly, M L ML, Ogushi, F F, Fells, G A GA and Crystal, R G RG..  (1988)  Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele..  American journal of human genetics,      [PMID:2901226]
20. Ciliberto, G G, Dente, L L and Cortese, R R..  (1985)  Cell-specific expression of a transfected human alpha 1-antitrypsin gene..  Cell,      [PMID:2985281]
21. Takahashi, H H and 8 more authors..  (1988)  Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida..  The Journal of biological chemistry,    (25):   [PMID:3262617]
22. Nukiwa, T T and 6 more authors..  (1986)  Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene..  The Journal of biological chemistry,    (5):   [PMID:3491072]
23. Coutelle, C C and 5 more authors..  (1985)  Construction and partial characterization of a human liver cDNA library..  Biomedica biochimica acta,      [PMID:3873938]
24. Riley, J H JH, Bathurst, I C IC, Edbrooke, M R MR, Carrell, R W RW and Craig, R K RK..  (1985)  Alpha 1-antitrypsin and serum albumin mRNA accumulation in normal, acute phase and ZZ human liver..  FEBS letters,    (23):   [PMID:3876243]
25. Long, G L GL, Chandra, T T, Woo, S L SL, Davie, E W EW and Kurachi, K K..  (1984)  Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant..  Biochemistry,    (9):   [PMID:6093867]
26. Bollen, A A and 8 more authors..  (1983)  Cloning and expression in Escherichia coli of full-length complementary DNA coding for human alpha 1-antitrypsin..  DNA (Mary Ann Liebert, Inc.),      [PMID:6319097]
27. Loebermann, H H, Tokuoka, R R, Deisenhofer, J J and Huber, R R..  (1984)  Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function..  Journal of molecular biology,    (15):   [PMID:6332197]
28. Rosenberg, S S, Barr, P J PJ, Najarian, R C RC and Hallewell, R A RA..  (1984)  Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin..  Nature,      [PMID:6387509]
29. Owen, M C MC, Brennan, S O SO, Lewis, J H JH and Carrell, R W RW..  (1983)  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder..  The New England journal of medicine,    (22):   [PMID:6604220]
30. Leicht, M M and 7 more authors..  (1982)  Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes..  Nature,    (24):   [PMID:6979715]
31. Kurachi, K K and 6 more authors..  (1981)  Cloning and sequence of cDNA coding for alpha 1-antitrypsin..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:7031661]
32. Carrell, R W RW and 6 more authors..  (1982)  Structure and variation of human alpha 1-antitrypsin..  Nature,    (22):   [PMID:7045697]
33. Faber, J P JP and 6 more authors..  (1994)  Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele..  American journal of human genetics,      [PMID:7977369]
34. Hildesheim, J J, Kinsley, G G, Bissell, M M, Pierce, J J and Brantly, M M..  (1993)  Genetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha 1-antitrypsin deficiency variant Pduarte..  Human mutation,      [PMID:8364590]
35. Song, H K HK, Lee, K N KN, Kwon, K S KS, Yu, M H MH and Suh, S W SW..  (1995)  Crystal structure of an uncleaved alpha 1-antitrypsin reveals the conformation of its inhibitory reactive loop..  FEBS letters,    (18):   [PMID:8543039]
36. Elliott, P R PR, Lomas, D A DA, Carrell, R W RW and Abrahams, J P JP..  (1996)  Inhibitory conformation of the reactive loop of alpha 1-antitrypsin..  Nature structural biology,      [PMID:8756325]
37. Ryu, S E SE, Choi, H J HJ, Kwon, K S KS, Lee, K N KN and Yu, M H MH..  (1996)  The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A..  Structure (London, England : 1993),    (15):   [PMID:8939743]
38. Lovegrove, J U JU and 5 more authors..  (1997)  A new alpha 1-antitrypsin mutation, Thr-Met 85, (PI Zbristol) associated with novel electrophoretic properties..  Annals of human genetics,      [PMID:9459000]
39. Elliott, P R PR, Abrahams, J P JP and Lomas, D A DA..  (1998)  Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation..  Journal of molecular biology,    (23):   [PMID:9466920]
40. Seixas, S S, Garcia, O O, Amorim, A A and Rocha, J J..  (2000)  A novel alpha-1-antitrypsin r281del variant found in a population sample from the Basque country..  Human mutation,      [PMID:10612848]
41. Jardi, R R and 7 more authors..  (1998)  Identification and molecular characterization of the new alpha-1-antitrypsin deficient allele PI Y barcelona (Asp256-->Val and Pro391-->His). Mutations in brief no. 174. Online..  Human mutation,      [PMID:10651487]
42. Dunstone, M A MA and 8 more authors..  (2000)  Cleaved antitrypsin polymers at atomic resolution..  Protein science : a publication of the Protein Society,      [PMID:10716194]
43. Elliott, P R PR, Pei, X Y XY, Dafforn, T R TR and Lomas, D A DA..  (2000)  Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease..  Protein science : a publication of the Protein Society,      [PMID:10933492]
44. Huntington, J A JA, Read, R J RJ and Carrell, R W RW..  (2000)  Structure of a serpin-protease complex shows inhibition by deformation..  Nature,    (19):   [PMID:11057674]
45. Kim, S S, Woo, J J, Seo, E J EJ, Yu, M M and Ryu, S S..  (2001)  A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops..  Journal of molecular biology,    (9):   [PMID:11178897]
46. Im, Hana H, Woo, Mi-Sook MS, Hwang, Kwang Yeon KY and Yu, Myeong-Hee MH..  (2002)  Interactions causing the kinetic trap in serpin protein folding..  The Journal of biological chemistry,    (29):   [PMID:12244055]
47. Zhang, Hui H, Li, Xiao-Jun XJ, Martin, Daniel B DB and Aebersold, Ruedi R..  (2003)  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry..  Nature biotechnology,      [PMID:12754519]
48. Dementiev, Alexey A, Simonovic, Miljan M, Volz, Karl K and Gettins, Peter G W PG..  (2003)  Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases..  The Journal of biological chemistry,    (26):   [PMID:12860985]
49. Bunkenborg, Jakob J, Pilch, Bartosz J BJ, Podtelejnikov, Alexandre V AV and Wiśniewski, Jacek R JR..  (2004)  Screening for N-glycosylated proteins by liquid chromatography mass spectrometry..  Proteomics,      [PMID:14760718]
50. Kristiansen, Troels Zakarias TZ and 8 more authors..  (2004)  A proteomic analysis of human bile..  Molecular & cellular proteomics : MCP,      [PMID:15084671]
51. Lewandrowski, Urs U, Moebius, Jan J, Walter, Ulrich U and Sickmann, Albert A..  (2006)  Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach..  Molecular & cellular proteomics : MCP,      [PMID:16263699]
52. Liu, Tao T and 6 more authors..  ()  Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry..  Journal of proteome research,      [PMID:16335952]
53. Kolarich, Daniel D, Weber, Alfred A, Turecek, Peter L PL, Schwarz, Hans-Peter HP and Altmann, Friedrich F..  (2006)  Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms..  Proteomics,      [PMID:16622833]
54. Shasany, Ajit K AK and 6 more authors..  (2007)  An alpha-1 antitrypsin genetic variant from India..  Indian journal of biochemistry & biophysics,      [PMID:17650587]
55. Marques, Patrícia Isabel PI and 8 more authors..  (2013)  SERPINA2 is a novel gene with a divergent function from SERPINA1..  PloS one,      [PMID:23826168]
56. Tagliabracci, Vincent S VS and 14 more authors..  (2015)  A Single Kinase Generates the Majority of the Secreted Phosphoproteome..  Cell,    (18):   [PMID:26091039]
57. Sheffield, William P WP and Bhakta, Varsha V..  (2016)  The M358R variant of α(1)-proteinase inhibitor inhibits coagulation factor VIIa..  Biochemical and biophysical research communications,    (12):   [PMID:26797521]
58. Esteghamat, Fatemehsadat F and 24 more authors..  (2019)  CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation..  Nature genetics,      [PMID:31358993]

Solution Calculators

Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.